Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 775

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 775
---
 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023 -09is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted. The adoption of ASU 2023 -09is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s consolidated financial statements. In November 2024, the FASB issued ASU 2024 -03, Disaggregation of Income Statement Expenses (“DISE”), a new accounting standard to improve the disclosures about an entity’s expenses and address requests from investors for more detailed information about the types of expenses included in commonly presented expense captions. The new standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with retrospective application permitted. The Company is evaluating the disclosure requirements related to the new standard and its impact on the Company’s consolidated financial statements. The Company has implemented all new accounting pronouncements currently in effect that may impact its consolidated financial statements and does not believe any other recently issued standards will have a material impact on its financial position or results of operations. Annex F-15 NLS PHARMACEUTICS LTD. AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Note 3 Prepaid Expenses and Other Current Assets: The Company’s prepaid expenses and other current assets consisted of the following as of December 31, 2024, and 2023:

|                                                 |     | December 31, |    2024 |     |   |    2023 |
|:------------------------------------------------|:----|:-------------|--------:|:----|:--|--------:|
| Vendor prepayments                              |     | $            |  65,237 |     | $ | 821,266 |
| VAT recoverable and other current assets        |     |              |  49,479 |     |   |  24,433 |
| Other short-term receivables                    |     |              |